To Stop Preventable Blindness in Children and Adolescents

Light for Sight is uniting clinical institutions, research groups, patient organizations and the private sector, with a single focus: to eliminate severe visual impairment among all children and adolescents with keratoconus.

Outreach. Education. Research. Access to treatment

World Keratoconus Day

2022 CXL Experts' Meeting
Congress Videos

Our Philosophy

Light for Sight is uniting clinical institutions, research groups, patient organizations and the private sector, with a single focus: to eliminate severe visual impairment among all children and adolescents with keratoconus.

Our flagship program is “Light for Sight 21”, which aims to reduce severe visual impairment among children and adolescents with Down Syndrome – who have a very high prevalence of the disease.

The sub400 Protocol

Individualized corneal cross-linking with riboflavin and UV-A in ultra-thin corneas: the sub400 protocol

What we do

Outreach: To promote awareness among patient groups (and families)
Education: To improve (vision) healthcare professional awareness
Access: Provide access to diagnosing and treatment of corneal diseases
Partners: To create a network of screening/treatment referral sites
Financing: To provide medical coverage for at-need patients
Research: To investigate, understand and treat the cause of keratoconus

Screen My Eyes
Support Our Mission
Screen My Friends
Support Our Mission
Light For Sight 21
Support Our Mission

Our Partners / Associates

Selected clinical institutions, research groups, patient organizations and the private sector in achieving the mission to eliminate severe visual impairment among all children and adolescents with keratoconus.

Posts

CROCS 2023 – CXL presentations and keratoconus screening

During the Croatian Organisation of Cataract and Refractive Surgery (CROCS) 2023 annual meeting held in Zadar, Croatia, on 12th and 13th October, Prof. Farhad Hafezi lectured on “CXL in 2023” and he and ELZA’s CEO, Nikki Hafezi, performed Croatia’s largest keratoconus in Down Syndrome screening event to date.